Association of polymorphisms in the estrogen receptor α gene with body fat distribution

[1]  A. Hartmann,et al.  A polymorphism but no mutations in the GADD45 gene in breast cancers , 1996, Human Genetics.

[2]  A. Hofman,et al.  polymorphisms with bone mineral density, vertebral bone area and fracture risk , 2003 .

[3]  M. Visser,et al.  Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. , 2003, Obesity research.

[4]  Yoshiji Yamada,et al.  Association of polymorphisms of the estrogen receptor α gene with bone mineral density of the femoral neck in elderly Japanese women , 2002, Journal of Molecular Medicine.

[5]  E. Snyder,et al.  The human obesity gene map: the 2001 update. , 2002, Obesity research.

[6]  P. Heine,et al.  The role of estrogen and estrogen receptor-α in male adipose tissue , 2001, Molecular and Cellular Endocrinology.

[7]  P. Lakatos,et al.  Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. , 2001, European journal of endocrinology.

[8]  D. Reid,et al.  Estrogen Receptor α Gene Polymorphisms and Bone Mineral Density: Haplotype Analysis in Women from the United Kingdom , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  P. Heine,et al.  The role of estrogen and estrogen receptor-alpha in male adipose tissue. , 2001, Molecular and cellular endocrinology.

[10]  R. Honkanen,et al.  The Protective Effect of Hormone‐Replacement Therapy on Fracture Risk Is Modulated by Estrogen Receptor α Genotype in Early Postmenopausal Women , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  G. Hawker,et al.  Alleles of the Estrogen Receptor α‐Gene and an Estrogen Receptor Cotranscriptional Activator Gene, Amplified in Breast Cancer‐1 (AIB1), Are Associated with Quantitative Calcaneal Ultrasound , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  K. Walker,et al.  Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women , 2000, Menopause.

[13]  S. Kikuchi,et al.  Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis , 2000, Journal of the Neurological Sciences.

[14]  M. Brandi,et al.  Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. , 2000, Human molecular genetics.

[15]  N. Piaseu,et al.  Oestrogen‐receptor‐α gene polymorphism affects response in bone mineral density to oestrogen in post‐menopausal women , 2000 .

[16]  F. Ando,et al.  A new comprehensive study on aging--the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). , 2000, Journal of epidemiology.

[17]  Y. Ouchi,et al.  Association of Estrogen Receptor β Gene Polymorphism with Bone Mineral Density , 2000 .

[18]  J. Després,et al.  Body fat distribution, the menopause transition, and hormone replacement therapy. , 2000, Diabetes & metabolism.

[19]  Y. Ouchi,et al.  Association of estrogen receptor beta gene polymorphism with bone mineral density. , 2000, Biochemical and biophysical research communications.

[20]  S. Chanprasertyothin,et al.  Oestrogen-receptor-alpha gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal women. , 2000, Clinical endocrinology.

[21]  R. Lorentzon,et al.  Estrogen receptor gene polymorphism, but not estradiol levels, is related to bone density in healthy adolescent boys: a cross-sectional and longitudinal study. , 1999, The Journal of clinical endocrinology and metabolism.

[22]  L. Zichella,et al.  Evaluation of the Body Composition and Fat Distribution in Long-Term Users of Hormone Replacement Therapy , 1999, Gynecologic and Obstetric Investigation.

[23]  A. Genazzani,et al.  Climacteric modifications in body weight and fat tissue distribution. , 1999, Climacteric : the journal of the International Menopause Society.

[24]  Mark L. Johnson,et al.  Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes , 1998, Human Genetics.

[25]  C. Bunten,et al.  Bone Mineral Density and Its Change in White Women: Estrogen and Vitamin D Receptor Genotypes and Their Interaction , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  E. Applegate,et al.  The relationship between fat distribution and coronary risk factors in sedentary postmenopausal women on and off hormone replacement therapy. , 1998, Obesity research.

[27]  J. Callés-Escandon,et al.  Menopause, central body fatness, and insulin resistance: effects of hormone‐replacement therapy , 1998, Coronary artery disease.

[28]  H. Schackert,et al.  An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancer. , 1997, European journal of cancer.

[29]  C. Cobelli,et al.  Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity. , 1997, Metabolism: clinical and experimental.

[30]  J. Vague.  The Degree of Masculine Differentiation of Obesities , 1996 .

[31]  Y. Ouchi,et al.  Association of bone mineral density with polymorphism of the estrogen receptor gene , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  Y. Ouchi,et al.  Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. , 1995, Biochemical and biophysical research communications.

[33]  P. Ferrari,et al.  The association of body fat location with haemodynamic and metabolic status in men and women aged 21-60 years. , 1991, Journal of clinical epidemiology.

[34]  A N Peiris,et al.  Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. , 1989, Diabetes/metabolism reviews.

[35]  P. Chambon,et al.  Genomic organization of the human oestrogen receptor gene. , 1988, The EMBO journal.

[36]  E. Thompson,et al.  The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. , 1988, American journal of human genetics.

[37]  A. Kissebah,et al.  Relation of Body Fat Distribution to Metabolic Complications of Obesity , 1982 .

[38]  A S Leon,et al.  A questionnaire for the assessment of leisure time physical activities. , 1978, Journal of chronic diseases.

[39]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[40]  H J Montoye,et al.  Estimation of habitual physical activity by questionnaire and interview. , 1971, The American journal of clinical nutrition.

[41]  J. Vague,et al.  The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. , 1956, The American journal of clinical nutrition.